Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen

ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.

Published

02/25/2021 at 5:15 am

Downloads

1